Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canopy Growth Corp T.WEED

Alternate Symbol(s):  T.WEED.DB | CGC

Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.


TSX:WEED - Post by User

Bullboard Posts
Comment by MrGhostTraderon Dec 08, 2017 11:38am
97 Views
Post# 27117859

RE:RE:Uh oh

RE:RE:Uh ohafter you repeatedly bash Falcon for his OGI strong hold now u are pumping ogi on here? get the fck out. clown
 

starsearcher40 wrote: Nice find Rainbow.  This fund has done VERY well, and the rebalancing is just a normal course of action.  That being said, it will put pressure on some names temporarily.  That money then has to go somewhere, so I would expect others down the list should similarly benefit.  Personally, I would bet Cronos, Supreme, and Organigram.  The other names....meh.


RainbowRunner wrote:

Cannabis ETF Required to Reduce Exposure to Large Canadian LPs

 

The Horizons Marijuana Life Sciences Index ETF (TSX: HMMJ) (OTC: HMLSF) has ballooned in size as the Canadian licensed producers (LPs) have soared, with the ETF net assets now at C$327.7MM as of 12/7. Its quarterly rebalancing is likely to occur within the next week, and this will lead to the sale of a portion of its three largest holdings, Aphria (TSX: APH) (OTC: APHQF), Aurora Cannabis (TSX: ACB) (OTC: ACBFF) and Canopy Growth (TSX: WEED) (OTC: TWMJF), all of which exceed the 10% maximum position size at the time of rebalancing.

Given the size of the ETF, this means that it will be selling $14.6mm of Aurora Cannabis, $10mm of Aphria and $6mm of Canopy Growth in the coming days, with the proceeds distributed into smaller members of its portfolio.

Solactive manages the benchmark index, the North American Marijuana Index. It posts guidelines that describe the index composition:

Based on the criteria outlined in Chapter 4, the Index Calculator determines the securities that are eligible for inclusion in the index. These securities are filtered according to the criteria below, resulting in the final index selection:

1. Minimum Market Capitalization of at least CAD 75 million. Existing index member need to have a Minimum Market Capitalization of at least CAD 67.5 million.
2. Minimum Average Monthly Daily Value Traded of at least CAD 250,000. Existing index member need to have a Minimum Average Monthly Daily Value Traded of at least CAD 200,000.

The index, which caps exposure to any single name at the time of rebalancing to 10% “with the excess weight being redistributed proportionally among all index components with a weight of less than 10%”, is set to be rebalanced on December 15th.

The ETF has made some changes since we last updated it, disposing of Arena Pharmaceuticals (NASDAQ: ARNA) and adding CannTrust (CSE: TRST) (OTC: CNNTF), Delta 9 Cannabis (CSE: NINE) (OTC: VNRDF), Newstrike Resources (TSXV: HIP) (OTC: NWKRF) and Radient Technologies (TSXV: RDI) (OTC: RDDTF). The  additions to Delta 9 and Newstrike were made on 12/7.

The ETF purposefully excludes companies that operate in the United States that are in violation of federal laws, which explains why the index members Liberty Health Sciences (CSE: LHS) (OTC: LHSIF) and Marapharm Ventures (TSXV: MDM) (OTC: MRPHF) are excluded. It also holds seven positions, outside of the index, including CannTrust, Delta 9, Emerald Health (TSXV: EMH) (OTC: EMHTF), ICC International Cannabis (TSXV: ICC) (OTC: ICCLF), Hydropothecary (TSXV: THCX) (OTC: HYYDF), Newstrike and WeedMD (TSXV: WMD) (OTC: WDDMF). Here is the complete list of holdings as of 12/6:

HMMJ has increased 44% since we wrote about the last rebalancing in September, but it has dramatically underperformed the six largest Canadian LPs:





Bullboard Posts